Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

LSTALSTA
Showing 8 of 16 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in LISATA THERAPEUTICS INC

GEODE CAPITAL MANAGEMENT, LLC holds 72,632 shares of LSTA (LISATA THERAPEUTICS INC), worth $246,999 as of 2026-Q2. The position was increased (+2.5% shares).

Current Value

$246,999

Current Shares

72,632

Total Value Change

+$79,918

Total Shares Change

+16,951

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
72,632
+2.5%
$246,9990.0%$3.40
16
2026-Q1
Increased
70,887
+10.0%
$355,2130.0%$4.31
18
2025-Q4
Increased
64,428
+1.9%
$119,8600.0%$1.92
15
2025-Q3
Increased
63,260
+3.6%
$165,7770.0%$2.53
16
2025-Q2
Increased
61,082
+0.9%
$175,9530.0%$2.80
15
2025-Q1
Increased
60,529
+8.3%
$142,2800.0%$2.35
16
2024-Q4
Increased
55,895
+0.4%
$166,6130.0%$2.94
15
2024-Q3
Increased
55,681
+9.4%
$167,0810.0%$2.91
17

Other major holders of LSTA: VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used